Table 1.
Antimicrobial drug–resistance patterns of 100 K. pneumoniae isolates
| Antibiotic |
Resistant
No (%) |
Intermediate
No (%) |
Sensitive
No (%) |
|---|---|---|---|
| Colistin (C0,10 µg) | 0 | 0 | 100 |
| Aztreonam (10 μg) | 56 | 8 | 36 |
| Meropenem (10 μg) | 20 | 10 | 70 |
| Gentamicin(10 µg) | 36 | 4 | 60 |
| Ciprofloxacin (30 μg) | 53 | 7 | 40 |
| Amikacin (30 µg) | 26 | 4 | 70 |
| Imipenem(10 μg) | 20 | 10 | 70 |
| Cefotaxime(30 µg) | 57 | 3 | 40 |
| Cefepime(FEP, 30 μg) | 37 | 10 | 53 |
| Tetracycline(TE,10 μg) | 50 | 7 | 43 |
| Ampicillin(AMP,10 μg) | 73 | 7 | 20 |
| Piperacillin(PIP,100 μg) | 57 | 3 | 40 |
| Ceftriaxone(CRO,30 μg) | 56 | 4 | 40 |
| Cefpodoxime(CPD,30μg) | 64 | 6 | 30 |
| Tigecycline(TGC,15μg) | 5 | 30 | 65 |
| Doripenem(DOR,10 μg) | 20 | 10 | 70 |
| Ertapenem(ETP, 10 μg) | 20 | 10 | 70 |
| Piperacillin/Tazobactam (PTZ,100/10μg) | 29 | 10 | 61 |
| Fosfomycin/Trometamol (FOT, 200 μg) | 3 | 12 | 85 |
| Ceftazidime (30 µg) | 54 | 6 | 40 |